Business Context and Reporting Period
This Form 8-K, dated February 21, 2017, reports a material definitive agreement entered into by Tronox Limited (the "Company"). The filing announces the Company's agreement to acquire the titanium dioxide business of The National Titanium Dioxide Company Ltd. ("Cristal") and its subsidiary. Concurrently, the Company announced its intent to sell its Alkali business to fund the transaction.
Key Financial Metrics and Transaction Terms
The transaction involves the following financial terms:
- Total Consideration: $1.673 billion in cash (subject to working capital adjustment) plus 37,580,000 Class A ordinary shares of the Company.
- Post-Transaction Ownership: The Seller (Cristal) will own approximately 24% of the Company's outstanding ordinary shares.
- Funding Sources: The cash consideration is expected to be funded through proceeds from asset sales (including the Alkali business and other non-core assets) and cash on hand.
- Termination Fees: The Company must pay a $100 million termination fee if the transaction fails to close by May 21, 2018, provided all conditions other than financing are satisfied. Additionally, the Company may reimburse up to $15 million in expenses if the transaction is terminated due to a failure to obtain the required shareholder vote.
Note: This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the Company's current operations. Financial results for the fourth quarter ended December 31, 2016, are referenced in an attached press release (Exhibit 99.1) but are not detailed within the text of this 8-K.
Material Changes and Strategic Shifts
The primary material change is the proposed acquisition of Cristal's titanium dioxide business, which represents a significant expansion of the Company's core operations. To facilitate this, the Company is divesting its Alkali business. Upon closing, the Company will designate two individuals chosen by Cristal to serve as Class A directors. The transaction is expected to close before the first quarter of 2018.
Guidance, Outlook, Risks, and Contingencies
Conditions to Closing: The transaction is subject to several critical conditions, including:
- Approval by a majority of Class A and Class B ordinary shares voting together.
- Listing approval for the Consideration Shares on the New York Stock Exchange.
- Antitrust approvals under the U.S. Hart-Scott-Rodino Act and other jurisdictions.
- Approval under the Foreign Acquisitions and Takeovers Act 1975 (Australia).
- Securing sufficient financing to fund the cash consideration.
Risks and Contingencies: Management highlights significant risks, including the potential failure to close due to lack of shareholder approval, financing failure, or regulatory delays. There is also a risk that expected synergies may not be realized or that the Company may face unanticipated increases in financing costs. The Company has agreed to indemnify Cristal for certain breaches and liabilities, subject to limitations.
Future Intent: Subject to negotiations, the Company intends to acquire Cristal's 500 MMT slag production facility in Saudi Arabia following the closing.
Investor Verification Checklist
- Verify the final terms of the Transaction Agreement and Shareholders Agreement filed as Exhibit 2.1.
- Confirm the status of regulatory approvals, particularly antitrust clearances in the U.S. and Australia.
- Monitor the progress of the Alkali business sale and other asset divestitures required to fund the $1.673 billion cash portion.
- Review the upcoming proxy statement for details on the shareholder vote required to approve the issuance of Consideration Shares.
- Assess the Company's ability to secure the necessary financing, as this is a specific condition precedent to closing.